Chicago Atlantic Real Estate Finance, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REFI research report →
Range $16 – $16
Price Chart
About the company
Chicago Atlantic Real Estate Finance, Inc. functions as a commercial real estate financing enterprise operating throughout the United States. Its primary activities include developing, arranging, and deploying capital into various secured debt instruments, notably first mortgage loans, which are collateralized by commercial properties.
- CEO
- Anthony Robert Cappell
- IPO
- 2021
- HQ
- Miami Beach, FL, US
Get TickerSpark's AI analysis on REFI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $215.48M
- P/E
- 6.91
- Fwd P/E
- 4.43
- PEG
- -0.24
- P/S
- 3.42
- P/B
- 0.70
- EV/EBITDA
- 11.22
- Div Yield
- 22.30%
- Gross Margin
- 82.54%
- Op Margin
- 49.64%
- Net Margin
- 42.63%
- ROE
- 8.85%
- ROIC
- 6.08%
Latest fiscal year · YoY change
- Revenue
- $63.10M+15.2%
- Gross Profit
- $54.82M+0.1%
- Op Income
- $36.01M
- Net Income
- $36.01M-2.8%
- EPS
- $1.71-10.9%
- OCF Growth
- +24.3%
- FCF Growth
- +24.3%
- 52W High
- $13.49
- 52W Low
- $8.22
- 50D MA
- $9.59
- 200D MA
- $10.87
- Beta
- 0.36
- RSI (14)
- 36
- Avg Volume
- 185.30K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Chicago Atlantic Real Estate Finance posted another solid quarter of distributable earnings and dividends, while emphasizing its differentiated cannabis lending model and the strategic rationale for a merger with LIEN.· November 10, 2026
- Adjusted distributable earnings were $0.49 per fully diluted share, and the company paid a $0.47 quarterly dividend for the 18th consecutive quarter.
- Net interest income was $12.5 million, down from $12.8 million in Q2, but was $15.1 million on an adjusted basis including Koach note cash interest proceeds.
- The portfolio totaled about $527.7 million across 28 portfolio companies with a 14.8% weighted average yield to maturity.
- Non-accruals were about 3.1% of total loan portfolio principal, down from about 3.7% in June mainly because the portfolio grew.
- Management said originations should slow in Q4 2026 as liquidity is largely deployed, while they continue working toward the LIEN merger and BDC election.
Third-quarter net interest income was $12.5 million, down $0.3 million or 2.3% from $12.8 million in the second quarter. On an adjusted basis including cash interest proceeds from the Koach notes, total net interest income was $15.1 million, about 18% higher, helped by about $2.6 million of interest and fee income from Koach, timing of deployments and repayments, and the impact of the 25 basis point prime rate increase. Distributable earnings per share were about $0.50 basic and $0.49 fully diluted, and the company paid a regular quarterly dividend of $0.47 per share. The loan portfolio totaled about $527.7 million with a 14.8% weighted average yield to maturity, and total leverage was 48% of book equity. Looking ahead, management said Q4 2026 originations are expected to slow, while the company continues to explore ways to expand liquidity and advance the proposed merger with LIEN.
Peter Sack focused on REFI’s niche positioning in cannabis-linked real estate credit, arguing the company’s portfolio is not well captured by broader mortgage REIT comparisons. He said REFI’s floating-rate, low-leverage structure should benefit from rate increases, and highlighted that every 25 basis point increase in interest rates is expected to improve quarterly distributable earnings by $0.015 per share. He also framed the LIEN merger as a way to overcome scale and investor-base constraints, saying a combined company could broaden opportunities and attract more institutional interest over time.
Phil Silverman concentrated on the financial presentation and the impact of the Koach transaction. He explained that Koach notes are shown as a reduction of equity under GAAP, not as assets, and said book value should accrete back as the notes are repaid; adjusted book value per share was $14.12 at September 30 versus $14.15 at June 30. He also cited a CECL reserve of about $12.3 million on loans held for investment, or 2.9% of outstanding principal, and said the company estimates a $1.8 million CECL reserve for Koach notes, or about 3% of principal. He noted that interest expense rose to $2.9 million from about $2.4 million in Q2 due to higher revolver borrowings, which averaged $95.5 million versus $67.5 million.
Analysts pressed on the loan pipeline, the impact of higher rates, the Koach transaction, and the steps remaining to close the LIEN merger. Management said pipeline activity was lower partly because of the quarter’s heavy funding pace and because liquidity is largely extended, but they expect possible opportunities from state election outcomes and from maturing medical markets such as Pennsylvania, Texas, and Georgia. On the merger, Phil Silverman said the process is still in SEC review, followed by two shareholder votes: election to be treated as a BDC and then the merger vote. Management also said the Koach structure is not a one-off; they expect more opportunities to sell properties at lower cap rates and reinvest at higher cap rates, though cadence is hard to forecast.
The bull case from the call is that REFI is producing high-yield lending returns with low leverage and a portfolio that management says is structurally helped by rising rates. The company is still generating distributable earnings above the dividend, Koach added meaningful income in the quarter, and management sees room to continue rotating assets and benefiting from the LIEN combination over time.
The main risks highlighted were limited scale, constrained liquidity, and a pipeline that management expects to slow in Q4 2026. Management also acknowledged that REFI has traded more like the broader mortgage REIT sector despite its different asset base, and the LIEN merger still depends on SEC review and multiple shareholder approvals. Non-accruals remain present at 3.1% of the portfolio, and there is no certainty that the hoped-for investor-base expansion from the merger will materialize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.5%
- Shares Outstanding
- 25.62M
- Float Shares
- 22.67M
of shares held by institutions
103 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.87M | ▲ 148.52K |
| Fielder Capital Group LLC | 1.08M | ▲ 95.47K |
| Vanguard Group Inc | 942.42K | ▲ 1.43K |
| Vanguard Capital Management LLC | 923.68K | ▲ 135.43K |
| State Street Corp | 498.45K | ▼ 739 |
| Van Eck Associates Corp | 340.79K | ▲ 340.79K |
| Hotchkis & Wiley Capital Management LLC | 324.20K | ▲ 324.20K |
| Northern Trust Corp | 196.02K | ▲ 49.06K |
| Segall Bryant & Hamill, LLC | 188.62K | 0 |
| Corient Private Wealth LP | 175.87K | ▲ 23.16K |
| Vanguard Fiduciary Trust Co | 163.80K | ▲ 47.91K |
| Cdc Financial, Inc. | 163.70K | 0 |
Held by 109 ETFs
Biggest fund positions in REFI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 27, 26 | Mazarakis John | buy | 7,530 |
| Aug 26, 26 | Mazarakis John | buy | 40,181 |
| Aug 21, 26 | Mazarakis John | buy | 145 |
| Aug 19, 26 | Sack Peter | buy | 2,000 |
| Aug 19, 26 | Sack Peter | buy | 1,500 |
| Aug 18, 26 | Sack Peter | buy | 1,500 |
| Aug 17, 26 | Mazarakis John | buy | 25,000 |
| Aug 17, 26 | Cappell Anthony | buy | 45,000 |
| Apr 20, 26 | Konigsberg Brandon | other | 6,324 |
| Apr 20, 26 | Kite David | other | 37,099 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our REFI coverage
Recent articles, reports, and earnings notes.
No research on REFI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate REFI report →Buy 8 November Dividend Power Dogs While You Can
seekingalpha.com · Nov 13
What Chicago Atlantic Real Estate Finance (REFI) Said on Its Q3 Earnings Call
marketbeat.com · Nov 10
Chicago Atlantic Real Estate Finance, Inc. (REFI) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 10
Chicago Atlantic Real Estate Finance Announces Third Quarter 2026 Financial Results
globenewswire.com · Nov 10
18 Ideal 'Safer' DiviDog Buys Readers Tagged In September
seekingalpha.com · Oct 21
Chicago Atlantic Real Estate Finance Schedules Third Quarter 2026 Earnings Release and Conference Call Date
globenewswire.com · Oct 20
Reviewing Chicago Atlantic Real Estate Finance (NASDAQ:REFI) and Ladder Capital (NYSE:LADR)
defenseworld.net · Oct 19
High-Yield REITs vs. 10-Year Treasuries: Which Is the Better Buy?
zacks.com · Oct 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.